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Estradiol renal receptor molecules and estradiol-dependent
antinatriuresis. A 35 % decrease in urinary excretion of sodium
was produced when 1713-estradiol was administered to adrenal-
ectomized male rats in doses of 40 jig/day. Such estrogen-
dependent retention of sodium independent of mineralocorticoid
secretion suggests the possibility of a direct effect of estrogens
on the renal tubule. We here report the presence of renal estradiol
receptor molecules in the cytosol fraction of rat kidney homo-
genates incubated at 4° C for 3.5 hr with 1 to 4 x 1O M
3H-estradiol-17t3. These estradiol receptor sites have an apparent
Kassociation of 6.1 x 1010 liters/mole and a maximal binding
capacity of 5.4 x 10—14 moles per mg of cytosol protein. A ten-
fold excess of non-radioactive estradiol reduced PH] estradiol
binding by 67%; the same amount of estriol reduced binding
by 45 %, while a series of nonestrogenic steroids had no significant
effect on binding. After rat kidney slices were incubated at 37° C
for 45 mm with io M 3H-estradiol prior to preparation of
subcellular fractions, a considerable amount of estradiol (1.5 x
10—13 moles per mg of protein) was extracted from the purified
nuclear fraction. The addition of a hundred-fold excess of non-
radioactive estradiol to the incubation medium reduced the
3H-estradiol in the nuclear fraction by 76%, while a hundred-
fold excess of aldosterone had no effect on nuclear content of
estradiol. These results compare favorably to those obtained
with receptor molecules from other estrogen-responsive tissues
and provide presumptive evidence for the involvement of renal
estradiol receptor sites in the effect of estrogens on sodium
excretion.
Molecules rénales réceptrices d'oestradiol et antinatriurèse
dépendante de I'oestradiol. Le 1713-oestradiol administrd a des
rats males, surrenalectomisés, a Ia dose de 40 jig/jour a produit
une diminution de 35 % de l'excrétion urinaire du sodium. Une
telle retention de sodium dépendante des oestrogènes, indépen-
dante des minéralocorticoides, suggére Ia possibilité d'un effet
direct des oestrogCnes sur le tube renal. Les auteurs rapportent la
presence de molecules rénales réceptrices d'oestradiol dans Ic
cytosol d'homogénats de reins de rats incubés a 4° C pendant
3.5 heures en presence de 3H oestradiol-17f3 ala concentration de
1 a 4 x l0M. Ces sites récepteurs ont un K d'association
apparent de 6.1 x 10101/mole et une capacité d'association
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maximale de 5.4 x 10—14 mole/mg de protéines du cytosol. Un
excés d'un facteur 10 d'oestradiol froid réduisit Ia combinaison
de l'oestradiol 3H de 67%; la même quantité d'oestriol réduisit
Ia combinaison de 45 %, cependant qu'une série de stéroides non
oestrogénes n'avait pas d'effets significatifs sur Ia combinaison.
Quand des tranches de rein de rat étaient incubées it 37° C
pendant 45 minutes en presence d'oestradiol 3H 10 9si avant
Ia preparation de fr: ctions subcellulaires, une quantitC consid-
érable d'oestradiol (1.5 x 10—13 moles par g de proteines) était
extraite de Ia fraction nucleaire purifiée. L'addition d'un excés
d'oestradiol non radioactif dans un facteur 100 au milieu d'in-
cubation réduisit l'oestradiol 3H dans Ia fraction nucléaire de
76% alors qu'un excés d'aldostérone dans un facteur 100 n'avait
pas d'effet sur le contenu nucléaire en oestradiol. Ces résultats
peuvent être favorablement compares a ceux obtenus avec les
molecules réceptrices d'autres tissus sensibles aux oestrogènes
et offrent un argument de prCsomption pour Ia mise en cause de
sites récepteurs rénaux de l'oestradiol dans l'effet des oestrogénes
sur l'excrétion du sodium.
Numerous observations indicate a possible correlation
between sodium retention and increased estrogen levels.
Sodium retention occurs during pregnancy [1, 2], together
with a large increase in plasma estrogen levels [3]. Estrogens
have been shown to decrease the daily sodium excretion
rate in normal humans [4]. Moreover, a recent study
reports decreased renal excretion of sodium in dogs treated
with low doses of 17D-estradiol (250 jig/day) under condi-
tions suggestive that the mechanism differs from that of
mineralocorticoids [5]. The present communication reports
marked retention of sodium in adrenalectomized male rats
in response to 40 jig/day of 1763-estradiol. Evidence that
estrogen-dependent retention of sodium is independent of
increased mineralocorticoid secretion suggests thepossibility
of a direct effect of estrogens on the renal tubule, mediated
perhaps by estrogen-specific binding sites. Characteristic
extranuclear and nuclear macromolecules which combine
with estradiol in vivo and in vitro to form specific hormone-
receptor complexes have already been identified in such
hormone-responsive tissues as the uterus, the vagina and
96 DeVries et al
the anterior pituitary gland [6—9]. The present report
demonstrates aldosterone-independent uptake of estradiol
into the nucle°tr component of rat kidney slices and the
existence of estrogen-specific macromolecular complexes
in the cytosol of renal extracts.
Material and Methods
Estradiol-173-6,7-3H with a specific activity of 46.6 Cu
mmole was obtained from New England Nuclear Co.
and used without further purification. Chromatographically
pure 1713-estradiol, estriol, testosterone, corticosterone and
aldosterone were obtained from Calbiochem; 6cc-methyl-
prednisolone was a gift of the Upjohn Company. Studies
of estradiol receptor molecules were carried out by adding
aliquots of the solutions of steroids dissolved in 95%
ethanol directly to the homogenate or incubation medium,
such that the final ethanol content never exceeded 1 %.
For the electrolyte excretion experiments, immature male
Wistar-Lewis rats (approximately 150 g) were adrenal-
ectomized under pentobarbital anesthesia and maintained
on 0.9% NaCl and standard laboratory chow ad libitum.
At 9:00 A.M. on the fifth day following adrenalectomy, the
rats were given the first of a series of five subcutaneous
injections, spaced 12 hours apart, of 20 hg of either
173-estradiol, aldosterone or vehicle in 0.2 ml sesame oil.
All food was removed following the fourth injection and
the saline drinking water was removed one hour prior
to the final injection. Immediately after the final injection,
each rat was weighed and placed in an individual metabolic
cage. Spontaneously voided urine, free of feces, was
collected during an interval of three hours when the animal
was without access to food or water. Just before the collec-
tion period and again at the end, each rat was milked of
residual bladder urine by gentle suprapubic pressure. Each
urine sample, including a thorough distilled water rinse of
the collection funnel, was analyzed for sodium and potas-
sium by flame photometry.
Adrenalectomized male Wistar-Lewis rats (approximately
350 g), kept aside for at least five days after adrenalectomy
in order to ensure low endogenous steroid levels, were
used throughout the experiments on estradiol receptor
molecules. Rats were sacrificed by cervical dislocation.
The kidneys were immediately excised, decapsulated and
placed in ice. All subsequent procedures were carried out
at 0 to 4° C. For the preparation of the soluble extract,
a 15% w/v homogenate in 0.25 M sucrose containing
3 mri CaCI2 and 6 m'vi NaN3 (as a preservative) was made
using teflon-glass homogenizers. The "cytosol fraction"
was obtained by sequential centrifugation at 15,000 X G
for 15 mm and 104,000 x G for 60 mm. To aliquots of cyto-
sol were added, in one experiment, various amounts
of 3R-estradjol, and in another, a constant level of
3H-estradiol together simultaneously with a ten-fold greater
amount of various other steroids. Following a 3.5 hr in-
cubation at 0° C, 0.5 ml aliquots were fractionated on
Bio-Gel P-b columns as described elsewhere [10] in order
to quantitate 3H-estradiol-macromolecular complexes.
To determine the sub-cellular localization of 3H-estradiol,
decapsulated kidneys were thinly sliced with a Stadie-
Riggs microtome. Using the first three slices from each
side of both kidneys, three equivalent groups of slices
were formed for each animal. The slices were placed in
beakers containing 50 ml of Krebs-Bicarbonate medium
(25 mit NaHCO3, 5.1 m KCI, 121 m'vi NaCl, 1.2mM
MgSO4, 1.0mM CaCI2, and 7.5 m glucose). The tissue
was preincubated for 20 mm at 37° C on a Dubnoff
Shaking Incubator, gassed with 95% 02—5% C02, and
finally transferred to 50 ml of fresh medium containing
for each of the three groups one of the following: a) 10 M
3H-estradiol alone, b) 10 M 3H-estradiol together with
l0 M non-radioactive estradiol, or c) b0 M 3H-estradiol
together with 10 M aldosterone. The incubation was con-
tinued for 45 mm. Homogenates of the slices were prepared
as above using 10.0 ml of 0.25 M sucrose and were centrif-
uged at 600 x G for 10 mm. The purified nuclear fraction
was obtained from the 600 x G sediment by centrifugation
through 2.2 M sucrose-3 mrvi CaC12 at 56,000 x o for 30 mm
[11]. The purified nuclear pellet was suspended in 1.0 ml of
H20 and the 3H-estradiol was recovered by extraction into
5.0 ml of cold dichloromethane. The 600 x G supernatant
was centrifuged at 104,000 x G for 60 mm, and a 0.5 ml ali-
quot of the soluble fraction was applied to a Bi'--Gel P-10
column. The eluate, containing only 3H-estradiol-macro-
molecular complexes, as well as an aliquot of the original
104,000 x G supernatant, was extracted with five volumes
of dichloromethane.
To determine the level of contamination of tissue with
plasma estradiol-binding molecules, four adrenalectomized
rats were killed by ether anesthesia. Blood was collected
in heparin via cardiac puncture. Two ml aliquots of plasma
diluted ten-fold with 0.25 M sucrose were added to tubes
containing either 3H-estradiol alone or 3H and non-radio-
active estradiol together, and were incubated at 0° C for
3.5 hr. Aliquots were then fractionated by gel filtration.
Radioactivity was assayed with a Nuclear-Chicago
Unilux 11-A liquid scintillation system using Bray's [12]
counting solution or a toluene base solution containing
Triton X-100 [10]. Quench was corrected by external
standardization and channels ratio. Protein determinations
were made by the method of Lowry et a! [13]. Where
applicable, data were analyzed statistically with the Student
t-test, grouped or paired comparisons. The 0.05 level
of probability was the criterion of significance.
Results
Table 1 indicates the results of an experiment on the
effect of chronic administration of 17 13-estradiol or aldo-
sterone on urinary sodium and potassium excretion in
immature male adrenalectomized rats. Group comparisons
of seven treated rats with seven control animals after 48 hr










Control 7 156± 10 359± 29 64± 10
Estradiol 7 148± 11 233±33 65± 8
P NS <0.02 NS
Aldosterone 8 151± 6 176± 24 75± 8
P NS <0.001 NS
a Male adrenalectomized rats received a series of five subcutaneous
injections, spaced 12 hr apart, of either 20 jig 1713-estradiol,
20 jig aldosterone or a placebo in sesame oil. Food was removed
12 hr and saline drinking water one hr prior to a three hr interval
during which urine was collected. Values given are the means
sa of the mean for each group. The significance of the difference
between the control and treated groups was analyzed with the
Student" t" test, grouped comparisons (" NS" means F> 0.05).
of subcutaneous administration of estradiol in oil at a dose
of 40 jig/day indicate a significant decrease of 35% in the
urinary excretion of sodium during the three hr collection
period. No significant difference in potassium excretion
was observed during this period. Group comparisons
of seven control rats with eight rats treated for 48 hr with
aldosterone at a dose of 40 jig/day indicate a significant
decrease of 51 % in sodium excretion during the three hr
collection period as a result of aldosterone administration.
Again, no significant effect on potassium excretion was
observed in these experimental conditions. The degree
of sodium retention produced by aldosterone was not
significantly greater than that produced by estradiol.
Studies of estradiol receptor molecules were carried
out in vitro, using either the soluble fraction of kidney
homogenates or kidney slices incubated at 37° C in the
presence of 3H-estradiol. The cytosol fraction of a 15%
kidney homogenate incubated at 4° C for 3.5 hr with
6.0 x l0 M 3H-estradiol contains between 4 and 7%
of the estradiol in the form of a complex with a molecular
weight greater than the 12,000 exclusion limit of Bio-Gel
P-b. The specificity of this macromolecular complex for
estrogenic compounds is shown in Table 2. The addition
of a ten-fold excess of non-radioactive estradiol reduced
the level of 3H-estradiol-macromolecular complexes by
67%. An excess of estriol was slightly less effective as a
competitor, reducing 3H-complexes by 45%. All of the non-
estrogenic steriods tested, including the potent mineralo-
corticoid aldosterone, had no significant competitive effect
when added in amounts ten times greater than 3H-estradiol.
Since estradiol-binding molecules are known to exist
in plasma, it is appropriate to consider the level of plasma
contamination in our tissue extracts. Using the blood of
four rats, it was found that a 10% plasma solution in-
cubated for 3.5 hr with 4.0 x 10 M 3H-estradiol contains
only 20 2% of the estradiol complexes present in a 15%
renal homogenate. More importantly, the amount of









a Cytosol was incubated for 3.5 hr at 4° C with 6.0x iO M
3H-estradiol alone or together with one of the listed steroids at
6 x 10—8 si. Bound 3H-estradiol was determined by fractiona-
tion on Bio-Gel P-l0. Values are the means of four experi-
ments SE.
bl®%3.2x 1013 mole of 3H-estradiol bound per ml of
cytosol (the equivalent of 13,000 cPM/ml).
3H-estradiol complexes is reduced by only 20 6% when a
ten-fold excess of cold estradiol is added to 10% plasma
simultaneously with 4.0 x 1O M 3H-estradiol. Thus, it
may be calculated that only a very small fraction, if any,
of the specific 3H-estradiol binding sites in kidney homo-
genates (i.e. those sites displaceable with non-radioactive
estradiol) can be due to contamination with plasma
estradiol-binding molecules.
The affinity of the cytosol-binding molecule for estradiol
was determined by varying the concentration of 3H-
estradiol over the range of 1.0 to 4.0 x 10 M. At each
concentration the important value was considered to be the
specific binding, which was determined for each sample
by subtracting the amount of 3H complexed non-specifically
in an identical aliquot containing the same concentration
of 3H-estradiol but with a thousand-fold excess of non-
radioactive estradiol. Fig. 1 presents the mean (± sE)results
of four such experiments in the form of a Scatchard
analysis [14], plotting the "specific" bound estradiol versus
the ratio of specific bound to "free" estradiol (i.e., the con-
centration of estradiol added minus bound estradiol, in-
cluding "non-specific" bound). The plot over this range
closely approximates a straight line, allowing us to estimate
Nm,c the maximal number of sites (from the intercept
where the ratio of specific bound to free estradiol nears
zero), and Kassociation, the affiftity of the receptor mole-
cules for estradiol (from the slope). The results of this
analysis indicate an average Kassociation of 6.1 x 1010 liters
mole and a maximal binding capacity of 2.9 x 10_12 mole
of estradiol/g of kidney (equivalent to 5.4 x l0 14moles/mg
of cytosol protein). The data were also analyzed using
double reciprocal plots, with essentially the same results.
Previous studies have demonstrated the specific uptake
of estradiol into the nuclear component of uterus tissue
and uterus homogenates [9, 15, 16]. A similar observation
for rat kidney tissue is reported in Table 3. Kidney slices
in three equivalent groups from each adrenalectomized
rat were preincubated briefly to dilute out plasma-binding
Table 1. Effect of estradiol and aldosterone on sodium and
potassium excretiona
Table 2. Effect of steroids on 3H-estradiol bindinga
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Fig. 1. Determination of the affinity and the maximal number of
specific estradiol-binding sites in renal cytosol. Four separate
experiments were conducted in which cytosol was incubated at
4°C for 3.5 hr with 1.0, 2.0 or 4.Ox 10 M 3H-estradiol, either
alone or together with a 1000-fold excess of non-radioactive
estradiol. Specifically bound estradiol was determined by sub-
tracting from each value the 3H-estradiol remaining bound in the
presence of nonradioactive steroid. Mean values (±SE) are
expressed as a Scatchard plot, pairing specific bound versus the
ratio of specific bound to free estradiol (calculated as described
in the text). Kasqoc (from the slope) is 6.1 x 1010 liters/mole,
while Nmax (from the x intercept) is 5.4 x 10—14 moles/mg protein
(cytosol contained an average of 7.1 mg protein per ml).
Table 3. Specific 3H-estradiol uptake into purified nuclei of
kidney slicesa
104,000 x G cytosol Purified
nuclearTotal Bio-Gel fractionCytosol P-b Eluate
Moles of 3H-estradiol extracted/mg
proteinx 10"
3H-estradiol alone (control) 15.5 0.61 14.6
3H plus iO— M estradiol 14.7 0.26 3.5
difference from control 0.8 0.9 0.34 0.06 11.1 1.5
(± SE)p NS <0.01 <0.001
% of 3H displaced 5 56 76
3H-plus lO M aldosterone 15.0 0.56 14.9
difference from control 0.6± 0.6 0.04± 0.06 —0.3± 0.8
P NS NS NS
% of 3H-displaced 3 7 0
a Three equivalent groups of kidney slices from each adrenal-
ectomized rat were incubated at 37° C for 45 mm with 10 M
3H-estradiol in the following conditions: a) with i0— M non-
radioactive estradiol, b) with iO— M aldosterone and c) without
added non-radioactive steroid. Various fractions were prepared
from the homogenates of the slices (see Methods) and
3H-estradiol was extracted into dichloromethane. Values are
the means of six experiments. The significance of the difference
from the control was analyzed with the Student "t" test,
paired comparisons (" NS" means P> 0.05). The 104,000 x G
cytosol had an average of 1.8 mg protein per ml, while the
purified nuclear fraction had a mean of 1.6 mg/mI.
proteins and then incubated at 37° C for 45 mm with
10 M 3H-estradiol in three conditions: a) with 10 M
non-radioactive estradiol, b) with b0 s aldosterone,
and c) without added non-radioactive steroid. The slices
were homogenized and various fractions were prepared as
previously described: the purified nuclear fraction, the
104,000 x G cytosol and the Bio-Gel P-10 fractionation
of the cytosol. The 3H-estradiol of each fraction was re-
covered by extraction into dichioromethane (99% of
3H-estradiol in aqueous solution partitions into dichioro-
methane; while 95% of the radioactivity is extracted from
the nuclear fraction). The results of six such experiments,
reported in Table 3, indicate that a significant amount
of 3H-estradiol was taken up by the nuclear component
of the kidney tissue (1.5 x l0 13 moles/mg protein). In the
presence of a hundred-fold excess of non-radioactive
estradiol, 76% of the radioactivity in the purified nuclear
fraction and 56 % of 3H-estradiol macromolecular com-
plexes found in the Bio-Gel P-b eluate of the cytosol were
displaced. The presence of i0 M aldosterone in the in-
cubation medium had no significant effect on the amount
of estradiol in the nuclear fraction or bound to the cytosol
fraction. Neither an excess of aldosterone nor an excess
of non-radioactive estradiol had any significant effect
on the total amount of 3H-estradiol in the cytosol. In view
of the undetermined yields of homogenization and frac-
tionation procedures, it is impossible to report quantitatively
the actual proportions of estradiol bound in the cytosol
or nuclear fractions, but with the procedures employed
here 9% of the total 3H-estradiol incorporated into the
tissue slices at the end of the incubation was recovered
in the purified nuclear fraction while 0.4% was found
in the form of cytosol macromolecular complexes.
Discussion
A number of studies, reviewed recently by Johnson et al
[5], demonstrate that estrogens decrease urinary sodium
excretion in dogs and in human subjects. A previous
study with rats failed to show an antinatriuretic effect of
estradiol during the first four hours following sub-
cutaneous injection in male adrenalectomized saline-
loaded rats [17]. The results summarized in Table 1, how-
ever, clearly indicate marked sodium retention in saline-
deprived adrenalectomized rats in response to chronic
estradiol administration. Potassium excretion was un-
affected under these conditions, but the lack of an effect
of estradiol on K+ excretion cannot be unequivocally
ascertained from these results, since chronic aldosterone
administration (which has a known kaliuretic response)
also failed to show an effect. Earlier work [17] suggests
that a low-potassium diet may be necessary to reveal the
kaliuretic action of steroids in rats.
The results presented here demonstrating the existence
of renal estradiol receptor sites are strikingly similar to
reported observations of other "target tissues" such as
C
2.0 2.5 3.0 3.5 3.8
Estradiol bound, moles/liter of cytosol x b_b
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uterus and vagina in a number of species. In vitro incuba-
tion with 3H-estradiol results in specific steroid uptake
into the nuclei of these tissues in roughly the same degree
as in renal tissue [9, 18]. The incorporation of estrogens
into rat uterus and vagina [19] and the binding of estradiol
to soluble receptor molecules from these tissues [15]
reveal estrogen specificity similar to kidney tissue, the level
of binding in these tissues being unaffected by the presence
of progesterone, testosterone or hydrocortisone. Moreover,
there appear to be at least two groups of binding sites in the
soluble fraction of rat [7, 20], calf [21] and human [22]
uterus extracts similar to those in rat renal cytosol: one
group of a limited number of sites shows a very high affinity
for estradiol, while another very large group of sites seems
to bind estradiol at a rate proportional to the free steroid
concentration over a wide range. These two groups of sites
were also found by this laboratory in the soluble fraction
of a kidney homogenate of a normal male dog; the
15,000 x o supernatant incubated with io M 3H-estradiol
for 3.5 hr at 4°C contained 4.9 x 10—15 moles of estradiol
in the bound form per mg of protein (unpublished observa-
tions). The addition of 10—6 frI non-radioactive estradiol
reduced the level of binding in the cytosol by 73 %, but had
no effect on 3H-estradiol binding in dog plasma.
For the binding sites in kidney to be physiologically
significant, however, they must have enough affinity to
compete for estrogens in the general circulation. Certainly
the affinity of renal estradiol-binding molecules is sufficient
to remove estradiol from serum estradiol-binding proteins,
which have a reported dissociation constant on the order
of iO to 10—6 M [23, 24]. It is more difficult to establish
unequivocally the relative affinities of renal binding sites
and those of other hormone-sensitive tissues. Affinity
constants have been reported as high as 1012 liters/mole
for human uterus supernatant [22] and as low as io9 liters/
mole for partially purified calf uterus [25], but widely
variable experimental conditions make quantitative com-
parisons of little value. The study most directly comparable
to our own, where the soluble fraction of rat uterus extracts
was incubated with 3F1-estradiol for 15 mm at 4° C, after
which the high-affinity 9.5 S component was isolated by
sucrose-density centrifugation [26], reports a Kassoejat ion of
1.4 x io liters/mole with the maximal number of sites
equal to lOx 10 moles/mg protein (a total of 8.9 x
10—13 moles per uterus). In comparison to this value, the
estradiol receptor molecule in rat kidney cytosol appears
to have a higher affinity (6.1 x 1010 liters/mole) but fewer
sites on a protein basis (5.4 x l0 14 moles/mg). In terms
of the rat's total organ mass, however, the kidney may
have as much as three times the number of cytosol-binding
sites as the uterus (about 3 x 10 12 moles per kidney versus
8.9 x 10— 13 moles per uterus).
Several mechanisms have been proposed [5] for estrogen-
induced sodium retention: a) estrogens may directly affect
the filtered load of sodium by decreasing glomerular filtra-
tion rate (GFR); b) estrogens may increase mineralo-
corticoid secretion or c) affect the activity of some other
sodium-retaining endocrine factor; or d) estrogens may
affect the renal tubules directly via specific receptor sites.
Various studies in the dog [27] and the human [28] have
failed to show an estrogen effect on GFR. A number of
observations make it unlikely that the estrogen effect
must be mediated by mineralocorticoid secretion: a)
estradiol-induced antinatriuresis can be demonstrated in
adrenalectomized male rats (Table 1); b) estrogen-induced
sodium retention has been shown in an Addisonian patient
[29]; and c) estradiol decreases sodium excretion in DOCA-
escaped dogs (i.e., dogs which had recovered sodium ba-
lance after a period of excessive mineralocorticoid dosage)
[5]. At present, there is no evidence implicating other
endocrine factors in the estrogen response on sodium
excretion. If estrogens, on the other hand, have a direct
effect on the renal tubules, one might expect to find in
kidney tissue a number of macromolecular sites with
a specific high affinity for the hormone and perhaps
some hormone interaction or hormone-induced effect
on the nuclear component. Evidence presented in this
paper indicating an uptake of estradiol into the nuclei of
rat kidney slices and the presence in renal extracts of
specific high-affinity estradiol-macromolecular complexes
seems to adequately satisfy these expectations. The fact
that a large excess of aldosterone has no competitive effect
on estradiol-binding either in the cytosol or in the nuclear
component suggests that the estrogen sites are independent
of mineralocorticoid receptors (which is consistent with
the observation of estradiol-induced antinatriuresis in
DOCA-escaped animals). The present investigation provides
presumptive evidence for the involvement of renal estradiol
receptor sites in estrogen-induced sodium retention. Future
studies, such as a comparison of the dose-response curve
of the antinatriuretic effect with the plasma levels of
estradiol and the affinity of the renal estradiol receptor,
will be required to further substantiate this involvement.
A secondary, but not unimportant, implication is that
estrogens may well have their own impact on kidney
metabolism and function, and if their presence is over-
looked or if they are used as control or non-functional
steroids in studies on effects of mineralocorticoids, mis-
leading interpretations could possibly result.
Acknowledgements
Research support provided by an American Heart
Association Grant-In-Aid is gratefully acknowledged.
During the interval of this work, James H. Ludens, Ph. D.,
was a N.I.H. Postdoctoral Fellow (AM-46927) and Dr.
Fanestil was an Established Investigator of the American
Heart Association and a Markle Scholar in Academic
Medicine.
Reprint requests to Dr. Darrell D. Fanestil, Department of
Medicine, School of Medicine, University of California at San
Diego, La Jolla, California 92037 U.S.A.
100 DeVries et a!
References
1. CHESLEY LC: Weight changes and water balance in normal
and toxic pregnancy. Am J Obstet Gynecol48:565—593, 1944
2. TAYLOR HC, JR, WARNER RC, WELSn CA: The relationship
of the estrogens and other placental hormones to sodium
and potassium balance at the end of pregnancy and in the
puerperium. Am J Obstet Gyneco! 38:748—777, 1939
3. Roy, EJ, MACKAY R: The concentration of oestrogens in
blood during pregnancy, J Obstet Gynaecol Brit Common-
wealth 69:13—17, 1962
4. PREEDY JRK, AITKEN EH: The effect of estrogen on water
and electrolyte metabolism. I. The normal. J Clin Invest
35:423—429, 1956
5. JOHNSON JA, DAvIs JO, BAUMBER JS, SCHNEIDER EG: Effects
of estrogens and progesterone on electrolyte balances in
normal dogs. Am J Physiol 219: 1691—1697, 1970
6. JENSEN EV, JACOBSON HI: Basic guides to the mechanism of
estrogen action. Recent Progr Hormone Res 18: 387—414, 1962
7. TOFT D, G0RSKI J: A receptor molecule for estrogens:
isolation from the rat uterus and preliminary characteriza-
tion. Proc Nat! Acad Sci 55:1574—1581, 1966
8. JENSEN EV, SuzuKI T, KAWASHIMA T, STUMPF WE, JUNG-
BLUT PW, DESOMBRE ER: A two-step mechanism for the
interaction of estradiol with rat uterus. Proc Nat! Acad Sc!
59:632—638, 1968
9. NOTEBOOM WD, GORSKI J: Stereospecific binding of estro-
gens in the rat uterus. Arch Biochem Biophys 111:559—568,
1965
10. RoBINsoN RG, FANESTIL DD: Assay of aldosterone by
competitive protein binding. Acta Endocrinol Suppl 147:275—
290, 1970
11. HERMAN TS, FIMOGNARI GM, EDELMAN IS: Studies on renal
aldosterone binding proteins. J Biol Chem 243:3849—3856,
1968
12. BRAY GA: A simple efficient liquid scintillator for counting
aqueous solutions in a liquid scintillation counter. Anal
Biochem 1:279—285, 1960
13. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ:
Protein measurement with the folin phenol reagent. J Biol
Chem 193:265—275, 1951
14. SCATCHARD G: The attractions of proteins for small mole-
cules and ions. Ann NY Acad Sc! 51:660—672, 1949
15. GORSKI J, TOFT D, SHYAMALA G, SMITH D, NOTIDES A:
Hormone receptors: studies on the interaction of estrogen
with the uterus. Recent Frog Hormone Res 24:45:80, 1968
16. SHYAMALA G, G0R5KI J: Interrelationship of estrogen recep-
tors in the nucleus and cytosol. J Ce!! Bio! 35:125 A—i 26A,
1967
17. FIMOGNARI GM, FANESTIL DD, EDELMAN 1S Induction of
RNA and protein synthesis in the action of aldosterone in
the rat. Am J Physiol 213:954—962, 1967
18. SHYAMALA G, GORSKI J: Estrogen receptors in the rat
uterus: studies on the interaction of cytosol and nuclear
binding sites. J Biol Chem 244:1097—1103, 1969
19. EISENFELD AJ, AXELROD J: Effect of steroid hormones,
ovariectomy, estrogen pretreatment, sex and immaturity on
the distribution of 3H-estradiol. Endocrinology 79:38-42,
1966
20. ALBERGA A, BAULIEU E-E: Binding of estradiol in castrated
rat endometrium in vivo and in vitro. Mo! Pharm 4:311—323,
1968
21. ERDOS T, BESSADA R, FRIES J: Binding of oestradiol to
receptor-substances present in extracts from calf uterus.
FEBS Letters 5:161—164, 1969
22. HAHNEL R: Properties of the estrogen receptor in the soluble
fraction of human uterus. Steroids 17:105—132, 1971
23. DAUGHADAY WH, MARIZ 1K: The binding of steroid
hormones by plasma proteins in Biological Activities of
Steroids in Relation to Cancer, edited by PINCUS G, VOLL-
MER EP, New York, Academic Press, 1960, p. 61
24. WESTPHAL U: Interactions between steroids and proteins in
Mechanisms of Action of Steroid Hormones, edited by VILLEE
CA, ENGEL LL, New York, Pergamon Press, 1961, p. 33
25. TALWAR GP, SOPORI ML, BIswAs DK, SEGAL SJ: Nature
and characteristics of the binding of oestradiol-17l to a
uterine macromolecular fraction. Biochem J 107:765—774,
1968
26. TOFT D, SHYAMALA G, G0RsKI J: A receptor molecule for
estrogens: studies using a cell-free system. Proc nat! Acad Sci
57:1740—1743, 1967
27. WHITEHL, HEINBECKERP, R0LFD: Some endocrine in-
fluences on renal function and cardiac output. Am J Physiol
149:404—417, 1947
28. DIGNAM WS, VOSKIAN J, AssAu NA: Effects of estrogens
on renal hemodynamics and excretion of electrolytes in
human subjects. J Clin Endocrinol Metab 16: 1032—1042, 1956
29. THORN GW, ENGEL LL: The effect of sex hormones on the
renal excretion of electrolytes. J Exptl Med 68:299—312, 1938
